Comparison between ABH Healthcare IPO and Telge Projects IPO.
ABH Healthcare IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Telge Projects IPO is a SME Bookbuilding proposed to list at BSE SME.
| ABH Healthcare IPO | Telge Projects IPO | |
|---|---|---|
| Logo | ![]() | ![]() |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Fedex Securities Pvt.Ltd. | Smart Horizon Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Shreni Shares Ltd. | |
| DRHP | DRHP ![]() | DRHP ![]() |
| RHP | RHP ![]() | |
| Final Prospectus | Final Prospectus ![]() | |
| Anchor Investor | Anchor Investor ![]() | |
| IPO Allotment URL | IPO Allotment URL ![]() |
The total issue size of ABH Healthcare IPO is up to ₹0.00 Cr whereas the issue size of the Telge Projects IPO is up to ₹25.87 Cr. The final issue price of ABH Healthcare IPO is and of Telge Projects IPO is ₹105.00 per share.
| ABH Healthcare IPO | Telge Projects IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹95.00 per share | |
| Issue Price (Upper) | ₹105.00 per share | |
| Issue Price (Final) | ₹105.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | |
| Fresh Issue Size | 34,29,000 shares | 24,63,600 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹25.87 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 34,29,000 shares | 24,63,600 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹25.87 Cr |
ABH Healthcare IPO opens on , while Telge Projects IPO opens on Sep 25, 2025. The closing date of ABH Healthcare IPO and Telge Projects IPO is , and Sep 29, 2025, respectively.
| ABH Healthcare IPO | Telge Projects IPO | |
|---|---|---|
| Anchor Bid Date | Sep 24, 2025 | |
| Issue Open | Sep 25, 2025 | |
| Issue Close | Sep 29, 2025 | |
| Basis Of Allotment (Tentative) | Sep 30, 2025 | |
| Initiation of Refunds (Tentative) | Oct 01, 2025 | |
| Credit of Share (Tentative) | Oct 01, 2025 | |
| Listing date (Tentative) | Oct 03, 2025 | |
| Anchor Lockin End date 1 | Oct 29, 2025 | |
| Anchor Lockin End date 2 | Dec 28, 2025 |
ABH Healthcare IPO P/E ratio is , as compared to Telge Projects IPO P/E ratio of 14.04.
| ABH Healthcare IPO | Telge Projects IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)Telge Projects Ltd.'s revenue increased by 105% and profit after tax (PAT) rose by 103% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 97.28 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 71.50 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 14.04 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹102.80 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 30.33% | 67.29% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 14.96% | 56.22% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 5.69 | 0.83 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 30.33% | 47.46% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the ABH Healthcare IPO Retail Individual Investors (RII) are offered 0 shares while in Telge Projects IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in ABH Healthcare IPO and 4,92,000 shares in Telge Projects IPO.
| ABH Healthcare IPO | Telge Projects IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 7,33,200 shares |
| Market Maker Reservation | 0 shares | 1,30,800 shares |
| QIB | 0 shares | 4,92,000 shares |
| NII | 0 shares | 3,72,000 shares |
| RII | 0 shares | 8,66,400 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 24,63,600 shares |
ABH Healthcare IPO subscribed in total, whereas Telge Projects IPO subscribed 2.99x.
| ABH Healthcare IPO | Telge Projects IPO | |
|---|---|---|
| QIB (times) | 5.41x | |
| NII (times) | 2.75x | |
| Big NII (times) | 3.00x | |
| Small NII (times) | 2.26x | |
| RII (times) | 1.72x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.99x |